Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies.

Autor: Raal FJ; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.)., Hegele RA; Department of Medicine and Biochemistry, Robarts Research Institute, University of Western Ontario, London, Canada (R.A.H., J.W.)., Ruzza A; Global Development (A.R., J.A.G.L., A.K.B.), Amgen Inc., Thousand Oaks, CA., López JAG; Global Development (A.R., J.A.G.L., A.K.B.), Amgen Inc., Thousand Oaks, CA., Bhatia AK; Global Development (A.R., J.A.G.L., A.K.B.), Amgen Inc., Thousand Oaks, CA., Wu J; Department of Medicine and Biochemistry, Robarts Research Institute, University of Western Ontario, London, Canada (R.A.H., J.W.)., Wang H; Global Biostatistics (J.W., H.W.), Amgen Inc., Thousand Oaks, CA., Gaudet D; Clinical Lipidology and Rare Lipid Disorders Unit, Community Genomic Medicine Centre and ECOGENE-21, Department of Medicine, Université de Montreal, Chicoutimi, Quebec, Canada (D.G.)., Wiegman A; Department of Paediatrics, Amsterdam UMC, Location AMC, the Netherlands (A.W.)., Wang J; Global Biostatistics (J.W., H.W.), Amgen Inc., Thousand Oaks, CA., Santos RD; Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital and Hospital Israelita Albert Einstein, Sao Paulo, Brazil (R.D.S.).

Publikováno v: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2024 May; Vol. 44 (5), pp. 1156-1164. Date of Electronic Publication: 2024 Mar 28.

Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial.

Autor: Bohula EA; TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: ebohula@bwh.harvard.edu., Marston NA; TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Ruzza A; Amgen, Thousand Oaks, CA., Murphy SA; TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., De Ferrari GM; Department of Medical Sciences, University of Turin and Department of Cardiology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Turin, Italy., Diaz R; Estudios Clínicos Latino America, Santa Fe, Argentina., Leiter LA; Li Ka Shing Knowledge Institute of St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Elliott-Davey M; Amgen, Cambridge, United Kingdom., Wang H; Amgen, Thousand Oaks, CA., Bhatia AK; Amgen, Thousand Oaks, CA., Giugliano RP; TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Sabatine MS; TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Publikováno v: American heart journal [Am Heart J] 2024 Mar; Vol. 269, pp. 179-190. Date of Electronic Publication: 2023 Dec 29.

Comparative genomic diversity analysis of copy number variations (CNV) in indicine and taurine cattle thriving in Europe and Indian subcontinent.

Autor: Singh VK; Animal Genetics and Breeding Division, ICAR-National Dairy Research Institute, Karnal, India., Singh S; Animal Genetics Division, ICAR-National Bureau of Animal Genetic Resources, Karnal, India., Nandhini PB; Animal Genetics and Breeding Division, ICAR-National Dairy Research Institute, Karnal, India., Bhatia AK; Animal Genetic Resources Division, ICAR-National Bureau of Animal Genetic Resources, Karnal, India., Dixit SP; Animal Genetics Division, ICAR-National Bureau of Animal Genetic Resources, Karnal, India., Ganguly I; Animal Genetics Division, ICAR-National Bureau of Animal Genetic Resources, Karnal, India.

Publikováno v: Animal biotechnology [Anim Biotechnol] 2023 Dec; Vol. 34 (8), pp. 3483-3494. Date of Electronic Publication: 2023 Jan 02.

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT.

Autor: Santos RD; Lipid Clinic Heart Institute, University of São Paulo Medical School Hospital and Hospital Israelita Albert Einstein, São Paulo, Brazil., Ruzza A; Global Clinical Development, Amgen, Thousand Oaks, CA, USA., Hovingh GK; Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands., Stefanutti C; Department of Molecular Medicine, Umberto I Hospital, Sapienza University of Rome, Rome, Italy., Mach F; Cardiology Department, Geneva University Hospitals, Geneva, Switzerland., Descamps OS; Department of Internal Medicine, Pole Hospitalier Jolimont, Reseau HELORA, La Louviere, Belgium., Bergeron J; Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec, QC, Canada., Wang B; Biostatistics Department, Amgen, Thousand Oaks, CA, USA., Bartuli A; Rare Diseases and Medical Genetics Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy., Buonuomo PS; Rare Diseases and Medical Genetics Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy., Greber-Platzer S; Division of Pediatric Pulmonology, Allergology and Endocrinology, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Luirink I; Department of Paediatrics, Amsterdam University Medical Center, Amsterdam, Netherlands., Bhatia AK; Global Clinical Development, Amgen, Thousand Oaks, CA, USA., Raal FJ; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Kastelein JJP; Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands., Wiegman A; Department of Paediatrics, Amsterdam University Medical Center, Amsterdam, Netherlands., Gaudet D; Clinical Lipidology and Rare Lipid Disorders Unit, Community Genomic Medicine Centre and Department of Medicine and ECOGENE-21, Université de Montreal, Chicoutimi, Québec, QC, Canada. Electronic address: daniel.gaudet@umontreal.ca.

Publikováno v: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2022 Oct; Vol. 10 (10), pp. 732-740. Date of Electronic Publication: 2022 Sep 05.

Development of New ‘Indigenous Dot-ELISA Kit’ as Sensitive Field Based Herd Screening Test for the Diagnosis of Johne’s Disease in the Domestic Buffalo Population

Autor: S.D. Audarya, Bhatia Ak, Audarya Sd, Ashok Kumar Bhat, Aseri Gk, Kuldeep Dhama, Bjorn John Stephen, Chaubey Kk, Stephen Bj, Jagdip Singh Soha, Shoor Vir Singh, Sahzad, Gajendra Kumar Aser, Saurabh Gupta, D. Chhabra, Sujata Jayaraman, Kundan Kumar Chaubey, Anjali Pachoori, Manju Singh, D. Chabra, Singh Sv, Sohal Js

Publikováno v: Asian Journal of Animal and Veterinary Advances. 11:44-52

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f73fe3f992c7353493d9f3dcc7cc4711
https://doi.org/10.3923/ajava.2016.44.52